How Omicron Infection Turbo-Charges Vaccinated People’s Immunity
People who are vaccinated and then get infected with omicron may be primed to overcome a broad range of coronavirus variants, early research suggests.
Read morePeople who are vaccinated and then get infected with omicron may be primed to overcome a broad range of coronavirus variants, early research suggests.
Read moreThe global pandemic drags on as contagious strains like BA.2 and BA.2.12.1 take hold…
Read moreA South African study based on blood samples found that the BA.4 and BA.5 sublineages of Omicron were more likely to evade antibodies produced by previous Omicron infections than the immunity provided by vaccinations…
Read moreThe U.S. has the highest levels of BA.2.12.1 so far. The post What do we know about the new omicron mutant? appeared first on Boston.com…
Read moreSymptoms of a Covid infection from the omicron BA.2 subvariant tend to be similar to the original omicron variant, though the subvariant is more transmissible.
Read more“At present there are a number of Omicron sub-lineages we’re following closely, including BA.2, BA.4 and BA.5 and another recombinant detected, made up of BA.1 and BA.2,” said WHO Director-General Tedros Adhanom Ghebreyesus today. That recombinant is called XE and, until today was the newest more-transmissible variant raising concern…
Read moreThe World Health Organization is analyzing a few dozen cases of two new subvariants of the Omicron strain to determine how infectious and dangerous they might be…
Read moreWhat do we know about “stealth omicron” so far? It’s an extra-contagious version of the omicron variant, but it doesn’t seem to cause more severe disease. Since it was first identified in November, BA.2 has been spreading around the globe, driving new surges in parts of Asia and Europe…
Read moreWhat do we know about “stealth omicron” so far…
Read moreThe COVID-19 symptoms caused by the Omicron variant tend to last about two days shorter than symptoms from the Delta variant, according to a new study published in The Lancet…
Read more